Incidence of type 1 and type 2 diabetes in youth in the US Virgin Islands, 2001-2010

2012 ◽  
Vol 14 (4) ◽  
pp. 280-287 ◽  
Author(s):  
Raynard E Washington ◽  
Trevor J Orchard ◽  
Vincent C Arena ◽  
Ronald E LaPorte ◽  
Eugene S Tull
Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 279-OR
Author(s):  
ALLISON SHAPIRO ◽  
DANA DABELEA ◽  
JEANETTE M. STAFFORD ◽  
RALPH DAGOSTINO ◽  
CATHERINE PIHOKER ◽  
...  

2020 ◽  
Vol 7 ◽  
pp. 2333794X2098134
Author(s):  
Goutham Rao ◽  
Elizabeth T. Jensen

The incidence of type 2 diabetes in children and adolescents in the United States rose at an annual rate of 4.8% between 2002-2003 and 2014-2015. Type 2 diabetes progresses more aggressively to complications than type 1 diabetes. For example, in one large epidemiological study, proliferative retinopathy affected 5.6% and 9.1% of children with type 1 and type 2 diabetes, respectively. Screening begins at age 10 or at onset of puberty, and is recommended among children with a BMI% ≥85 with risk factors such as a family history and belonging to a high risk racial or ethnic or racial group. HbA1C% is preferred for screening as it does not require fasting. As distinguishing between type 1 and type 2 diabetes is not straightforward, all children with new onset disease should undergo autoantibody testing. Results of lifestyle interventions for control of type 2 diabetes have been disappointing, but are still recommended for their educational value and the potential impact upon some participants. There is limited evidence for the benefit of newer mediations. Liraglutide, a GLP-1 agonist, however, has been shown to significantly reduce HbA1C% in one study and is now approved for children. Liraglutide should be considered as second line therapy.


2020 ◽  
Author(s):  
Brian J. Wells ◽  
Kristin M. Lenoir ◽  
Lynne E. Wagenknecht ◽  
Elizabeth J. Mayer-Davis ◽  
Jean M. Lawrence ◽  
...  

<u>Objective:</u> Diabetes surveillance often requires manual medical chart reviews to confirm status and type. This project aimed to create an electronic health record (EHR)-based procedure for improving surveillance efficiency through automation of case identification. <p><u> </u></p> <p><u>Research Design and Methods:</u> Youth (< 20 years) with potential evidence of diabetes (N=8,682) were identified from EHRs at three children’s hospitals participating in the SEARCH for Diabetes in Youth Study. True diabetes status/type was determined by manual chart reviews. Multinomial regression was compared with an ICD-10 rule-based algorithm in the ability to correctly identify diabetes status and type. Subsequently, the investigators evaluated a scenario of combining the rule based algorithm with targeted chart reviews where the algorithm performed poorly.</p> <p> </p> <p><u>Results:</u> The sample included 5308 true cases (89.2% type 1 diabetes). The rule-based algorithm outperformed regression for overall accuracy (0.955 vs 0.936). Type 1 diabetes was classified well by both methods: sensitivity (<i>Se</i>) (>0.95), specificity (<i>Sp</i>) (>0.96), and positive predictive value (PPV) (>0.97). In contrast, the PPVs for type 2 diabetes were 0.642 and 0.778 for the rule-based algorithm and the multinomial regression, respectively. Combining the rule-based method with chart reviews (n=695, 7.9%) of persons predicted to have non type 1 diabetes resulted in perfect PPV for the cases reviewed, while increasing overall accuracy (0.983). The sensitivity, specificity, and PPV for type 2 diabetes using the combined method were >=0.91. </p> <p> </p> <p><u>Conclusions</u>: An ICD-10 algorithm combined with targeted chart reviews accurately identified diabetes status/type and could be an attractive option for diabetes surveillance in youth. </p> <br>


2018 ◽  
Vol 32 (6) ◽  
pp. 545-549 ◽  
Author(s):  
Kristi Reynolds ◽  
Sharon H. Saydah ◽  
Scott Isom ◽  
Jasmin Divers ◽  
Jean M. Lawrence ◽  
...  

Diabetes Care ◽  
2016 ◽  
Vol 40 (1) ◽  
pp. 46-53 ◽  
Author(s):  
Maria Grau-Pérez ◽  
Chin-Chi Kuo ◽  
Miranda Spratlen ◽  
Kristina A. Thayer ◽  
Michelle A. Mendez ◽  
...  

Diabetes Care ◽  
2009 ◽  
Vol 32 (Supplement_2) ◽  
pp. S99-S101 ◽  
Author(s):  
E. J. Mayer-Davis ◽  
R. A. Bell ◽  
D. Dabelea ◽  
R. D'Agostino ◽  
G. Imperatore ◽  
...  

2022 ◽  
Author(s):  
Faisal S. Malik ◽  
Katherine A. Sauder ◽  
Scott Isom ◽  
Beth A. Reboussin ◽  
Dana Dabelea ◽  
...  

<b>OBJECTIVES: </b>To describe temporal trends and correlates of glycemic control in youth and young adults (YYA) with youth-onset diabetes. <p><b>RESEARCH DESIGN AND METHODS: </b>The study included 6,492 participants with type 1 or type 2 diabetes from the SEARCH for Diabetes in Youth study. Participant visit data were categorized into time periods 2002-2007, 2008-2013 and 2014-2019, diabetes durations of 1-4, 5-9, and 10+ years, and age groups 1-9, 10-14, 15-19, 20-24, 25+ years. Participants contributed one randomly selected data point to each duration and age group per time period. Multivariable regression models were used to test differences in hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) over time by diabetes type. Models were adjusted for site, age, sex, race/ethnicity, household income, health insurance status, insulin regimen and diabetes duration, overall and stratified for each duration and age group.</p> <p><b>RESULTS: </b>Adjusted mean HbA<sub>1c</sub> for the 2014-2019 cohort of YYA with type 1 diabetes was 8.8%±0.04%. YYA with type 1 diabetes in the 10-14, 15-19, and 20-24 age groups from the 2014-2019 cohort had worse glycemic control than the 2002-2007 cohort. Race/ethnicity, household income and treatment regimen predicted differences in glycemic control in 2014-2019 type 1 diabetes participants. Adjusted mean HbA1c was 8.6%±0.12% for 2014-2019 YYA with type 2 diabetes. Participants age 25+ with type 2 diabetes had worse glycemic control relative to the 2008-2013 cohort. Only treatment regimen was associated with differences in glycemic control in type 2 diabetes participants.</p> <p><b>CONCLUSIONS: </b>Despite advances in diabetes technologies, medications, and dissemination of more aggressive glycemic targets, many current YYA are less likely to achieve desired glycemic control relative to earlier cohorts.</p> <br>


Sign in / Sign up

Export Citation Format

Share Document